The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations.Joachim Albers,Manja Friese-Hamim,Anderson Clark,Oliver Schadt,Gina Walter-Bausch,Christopher Stroh,Andreas Johne,Niki Karachaliou,Andree Blaukatpubmed（2023）引用 6|浏览3关键词MET SignalingAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
